Cited by 255Regulation of Appetite and ObesityGDF15 and Related BiomarkersNausea and vomiting management

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

GDF15 Induces Anorexia through Nausea and Emesis

Open access

Borner, Tito, Shaulson, Evan D., Ghidewon, Misgana Y., Barnett, Amanda B., Horn, Charles C., Doyle, Robert P., Grill, Harvey J., Hayes, Matthew R., De Jonghe, Bart C.·2020·Cell Metabolism

DOI 10.1016/j.cmet.2019.12.004PMC PMC7161938

Open this paper in CoChat — free account Open PDF

Abstract

Growth differentiation factor 15 (GDF15) is a cytokine that reduces food intake through activation of hindbrain GFRAL-RET receptors and has become a keen target of interest for anti-obesity therapies. Elevated endogenous GDF15 is associated with energy balance disturbances, cancer progression, chemotherapy-induced anorexia, and morning sickness. We hypothesized that GDF15 causes emesis and that its anorectic effects are related to this function. Here, we examined feeding and emesis and/or emetic-like behaviors in three different mammalian laboratory species to help elucidate the role of GDF15 in these behaviors. Data show that GDF15 causes emesis in Suncus murinus (musk shrews) and induces behaviors indicative of nausea/malaise (e.g., anorexia and pica) in non-emetic species, including mice and lean or obese rats. We also present data in mice suggesting that GDF15 contributes to chemotherapy-induced malaise. Together, these results indicate that GDF15 triggers anorexia through the induction of nausea and/or by engaging emetic neurocircuitry.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2019.12.004

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Basch, E., Prestrud, A. A., Hesketh, P. J., Kris, M. G., Feyer, P., Somerfield, M. R., Chesney, M., Clark-Snow, R. A., Flaherty, A. M. C., Freundlich, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4614 · Cited by 1,058
Conditioned Aversion to Saccharin Resulting from Exposure to Gamma Radiation
García, J., Kimeldorf, D. J., & Koelling, R. A. (1955) · Science · doi:10.1126/science.122.3160.157 · Cited by 1,011
Chemotherapy-Induced Nausea and Vomiting
Hesketh, P. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706547 · Cited by 833
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Mullican, S. E., Lin-Schmidt, X., Chin, C.-N., Chavez, J. A., Furman, J. L., Armstrong, A. A., Beck, S. C., South, V. J., Dinh, T. Q., Cash-Mason, T. D., et al. (2017) · Nature Medicine · doi:10.1038/nm.4392 · Cited by 774
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Emmerson, P. J., Wang, F., Du, Y., Liu, Q., Pickard, R. T., Gonciarz, M. D., Coskun, T., Hamang, M. J., Sindelar, D. K., Ballman, K. K., et al. (2017) · Nature Medicine · doi:10.1038/nm.4393 · Cited by 675
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Yang, L., Chang, C.-C., Sun, Z., Madsen, D., Zhu, H., Padkjær, S. B., Wu, X., Huang, T., Hultman, K., Paulsen, S. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4394 · Cited by 668
Non-Homeostatic Body Weight Regulation Through a Brainstem-Restricted Receptor for GDF15
Hsu, J.-Y., Crawley, S., Chen, M., Ayupova, D. A., Lindhout, D. A., Higbee, J., Kutach, A., Joo, W., Gao, Z., Fu, D., et al. (2017) · Nature · doi:10.1038/nature24042 · Cited by 616
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W.-W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., et al. (2007) · Nature Medicine · doi:10.1038/nm1677 · Cited by 612
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Patel, S., Alvarez-Guaita, A., Melvin, A., Rimmington, D., Dattilo, A., Miedzybrodzka, E. L., Cimino, I., Maurin, A.-C., Roberts, G. P., Meek, C. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.016 · Cited by 509 · cited 6×
“Since this cluster of findings, numerous reports and reviews have demonstrated promise for GDF15-GFRAL signaling in obesity treatment (Frikke-Schmidt et al., 2019; Patel et al., 2019; Tsai et al., 2018).”
BackgroundResultInfluential

Flagged first, then by citations

Show all 64 references

Sorted by citations

Anti-obesity drug discovery: advances and challenges
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Wang, D., Day, E. A., Townsend, L. K., Djordjevic, D., Jørgensen, S. B., & Steinberg, G. R. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00529-7 · Cited by 543
Area postrema cell types that mediate nausea-associated behaviors
Zhang, C., Kaye, J. A., Cai, Z., Wang, Y., Prescott, S. L., & Liberles, S. D. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.010 · Cited by 263
Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems
Zhong, W., Shahbaz, O., Teskey, G., Beever, A., Kachour, N., Venketaraman, V., & Darmani, N. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115797 · Cited by 291
GDF15: a hormone conveying somatic distress to the brain
Lockhart, S. M., Saudek, V., & O’Rahilly, S. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa007 · Cited by 256
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252
The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Breit, S. N., Brown, D. A., & Tsai, V. W.-W. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022020-045449 · Cited by 237
GDF15 linked to maternal risk of nausea and vomiting during pregnancy
Fejzo, M. S., Rocha, N., Cimino, I., Lockhart, S. M., Petry, C. J., Kay, R. G., Burling, K., Barker, P., George, A. L., Yasara, N., et al. (2023) · Nature · doi:10.1038/s41586-023-06921-9 · Cited by 245
GIP receptor agonism attenuates GLP-1 receptor agonist induced nausea and emesis in preclinical models
Borner, T., Geisler, C. E., Fortin, S. M., Cosgrove, R., Alsina-Fernandez, J., Dogra, M., Doebley, S., Sanchez-Navarro, M. J., Leon, R. M., Gaisinsky, J., et al. (2021) · Diabetes · doi:10.2337/db21-0459 · Cited by 202
Self-citation
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
Breen, D. M., Kim, H., Bennett, D., Calle, R. A., Collins, S. M., Esquejo, R. M., He, T., Joaquim, S., Joyce, A. P., Lambert, M. A., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.023 · Cited by 187
A genetic map of the mouse dorsal vagal complex and its role in obesity
Ludwig, M. Q., Cheng, W., Gordian, D., Lee, J., Paulsen, S. J., Hansen, S. N., Egerod, K. L., Barkholt, P., Rhodes, C. J., Secher, A., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00363-1 · Cited by 186
Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.10.004 · Cited by 173
Central nervous system regulation of organismal energy and glucose homeostasis
Myers, M. G., Affinati, A. H., Richardson, N. E., & Schwartz, M. W. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00408-5 · Cited by 165
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
Rausch, V., Sala, V., Penna, F., Porporato, P. E., & Ghigo, A. (2021) · Oncogenesis · doi:10.1038/s41389-020-00288-6 · Cited by 149
Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control
Meouchy, P., Wahoud, M., Allam, S., Chedid, R., Karam, W., & Karam, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012305 · Cited by 176
Systemic Immunometabolism: Challenges and Opportunities
Lercher, A., Baazim, H., & Bergthaler, A. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.012 · Cited by 144
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Melero, I., Luken, M. D. M., de Velasco, G., Garralda, E., Martín-Liberal, J., Joerger, M., Alonso, G., Goebeler, M.-E., Schüler, M., König, D., et al. (2024) · Nature · doi:10.1038/s41586-024-08305-z · Cited by 144
Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise
Klein, A. B., Nicolaisen, T. S., Ørtenblad, N., Gejl, K. D., Jensen, R., Fritzen, A. M., Larsen, E. L., Karstoft, K., Poulsen, H. E., Morville, T. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21309-x · Cited by 138
Mast cells link immune sensing to antigen-avoidance behaviour
Plum, T., Binzberger, R., Thiele, R., Shang, F., Postrach, D., Fung, C., Fortea, M., Stakenborg, N., Wang, Z., Tappe‐Theodor, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06188-0 · Cited by 131
Hindbrain circuits in the control of eating behaviour and energy balance
Cheng, W., Gordian, D., Ludwig, M. Q., Pers, T. H., Seeley, R. J., & Myers, M. G. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00606-9 · Cited by 129
The Role of GDF15 as a Myomitokine
Johann, K., Kleinert, M., & Klaus, S. (2021) · Cells · doi:10.3390/cells10112990 · Cited by 125
The windsor definition for hyperemesis gravidarum: A multistakeholder international consensus definition
Jansen, L. A. W., Koot, M. H., Hooft, J. V. ’., Dean, C., Bossuyt, P. M., Ganzevoort, W., Gauw, N., van der Goes, B. Y., Rodenburg, J., Roseboom, T. J., et al. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.09.004 · Cited by 121
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Benichou, O., Coskun, T., Gonciarz, M. D., Garhyan, P., Adams, A. C., Du, Y., Dunbar, J. D., Martin, J. A., Mather, K. J., Pickard, R. T., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.011 · Cited by 115
Activation of the hypothalamic–pituitary–adrenal axis by exogenous and endogenous GDF15
Cimino, I., Kim, H., Tung, Y. C. L., Pedersen, K., Rimmington, D., Tadross, J. A., Kohnke, S., Neves‐Costa, A., Barros, A., Joaquim, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106868118 · Cited by 106
GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss
Borner, T., Wald, H. S., Ghidewon, M. Y., Zhang, B., Wu, Z., Jonghe, B. C. D., Breen, D. M., & Grill, H. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107543 · Cited by 101
Self-citation
GFRAL-expressing neurons suppress food intake via aversive pathways
Sabatini, P. V., Frikke‐Schmidt, H., Arthurs, J., Gordian, D., Patel, A. R., Rupp, A. C., Adams, J. M., Wang, J., Jørgensen, S. B., Olson, D. P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021357118 · Cited by 103
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?
Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 97
The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling
Worth, A. A., Shoop, R., Tye, K., Feetham, C. H., D’Agostino, G., Dodd, G. T., Reimann, F. M., Gribble, F. M., Beebe, E., Dunbar, J. D., et al. (2020) · eLife · doi:10.7554/elife.55164 · Cited by 92
Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response
Kang, S., Choi, M. J., Jung, S.-B., Chung, H. K., Chang, J. Y., Kim, J. T., Kang, Y. E., Lee, J. H., Hong, H. J., Jun, S. M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102181 · Cited by 91
Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight
Zhang, S., Bruce, K., Danaei, Z., Li, R. J. W., Barros, D. R., Kuah, R., Lim, Y.-M., Mariani, L. H., Cherney, D. Z. I., Chiu, J. F. M., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.014 · Cited by 92
GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH
Kim, K. H., & Lee, M. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129834 · Cited by 78
The brain–body energy conservation model of aging
Shaulson, E. D., Cohen, A. A., & Picard, M. A. (2024) · Nature Aging · doi:10.1038/s43587-024-00716-x · Cited by 80
Self-citation
Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management
He, Y., Zheng, J., Ye, B., Dai, Y., & Nie, K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115787 · Cited by 77
GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior
Samms, R. J., Cosgrove, R., Snider, B. M., Furber, E. C., Droz, B. A., Briere, D. A., Dunbar, J. D., Dogra, M., Alsina‐Fernandez, J., Borner, T., et al. (2022) · Diabetes · doi:10.2337/db21-0848 · Cited by 71
Self-citation
Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach
Kadakia, K. C., Hamilton‐Reeves, J. M., & Baracos, V. E. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_389942 · Cited by 71
Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs
Eisenstein, A. S., Hilliard, B. K., Pope, S. D., Zhang, C., Taskar, P., Waizman, D. A., Israni-Winger, K., Tian, H., Luan, H. H., & Wang, A. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.015 · Cited by 68
GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer
Ahmed, D. S., Isnard, S., Lin, J. C.-Y., Routy, B., & Routy, J. (2020) · Journal of Cancer · doi:10.7150/jca.50376 · Cited by 71
COVID‐19, nausea, and vomiting
Andrews, P. L. R., Cai, W., Rudd, J. A., & Sanger, G. J. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15261 · Cited by 63
Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
Li, J., Hu, X., Xie, Z., Li, J., Huang, C. L., & Huang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116809 · Cited by 72
Creating the amylin story
Lutz, T. A. (2022) · Appetite · doi:10.1016/j.appet.2022.105965 · Cited by 59
Neural Mechanisms of Cancer Cachexia
Olson, B. G., Diba, P., Korzun, T., & Marks, D. L. (2021) · Cancers · doi:10.3390/cancers13163990 · Cited by 62
Whole‐exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum
Fejzo, M. S., MacGibbon, K., First, O., Quan, C., & Mullin, P. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17129 · Cited by 65
Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis
Reyes, J., & Yap, G. S. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200641 · Cited by 56
Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy
Johansen, V. B. I., Petersen, J., Lund, J., Mathiesen, C. V., Fenselau, H., & Clemmensen, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.010 · Cited by 53
Growth differentiation factor 15 ( GDF15 ) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms
Ghidewon, M., Wald, H. S., McKnight, A. D., De Jonghe, B. C., Breen, D. M., Alhadeff, A. L., Borner, T., & Grill, H. J. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14663 · Cited by 51
Self-citation
Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients
Molfino, A., Amabile, M. I., Imbimbo, G., Rizzo, V., Pediconi, F., Catalano, C., Emiliani, A., Belli, R., Ramaccini, C., Parisi, C., et al. (2020) · Cancers · doi:10.3390/cancers13010099 · Cited by 52
GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Xiao, Q.-A., He, Q., Zeng, J., & Xia, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112582 · Cited by 50
Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus
Aguilar-Recarte, D., Barroso, E., Palomer, X., Wahli, W., & Vázquez‐Carrera, M. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.08.004 · Cited by 51
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 57
Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy
Sanchez-Garrido, M. A., Serrano-López, V., Ruíz-Pino, F., Vazquez, M. J., Rodríguez-Martín, A., Torres, E., Velasco, I., Rodríguez, A., Chicano‐Gálvez, E., Mora-Ortiz, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52898-y · Cited by 53
Cachexia, a Systemic Disease beyond Muscle Atrophy
Wyart, E., Bindels, L. B., Mina, E., Menga, A., Stanga, S., & Porporato, P. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228592 · Cited by 51
Growth Differentiation Factor 15 Regulates Oxidative Stress-Dependent Ferroptosis Post Spinal Cord Injury by Stabilizing the p62-Keap1-Nrf2 Signaling Pathway
Xia, M., Zhang, Q., Zhang, Y., Li, R., Zhao, T., Chen, L., Liu, Q., Zheng, S., Li, H., Qian, Z., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.905115 · Cited by 46
The Nutritional Challenges of Cancer Cachexia
Gaafer, O., & Zimmers, T. (2021) · JPEN - Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2287 · Cited by 39
Beyond classical immunity: Mast cells as signal converters between tissues and neurons
Plum, T., Feyerabend, T. B., & Rodewald, H.-R. (2024) · Immunity · doi:10.1016/j.immuni.2024.11.016 · Cited by 42
Loss of transient receptor potential channel 5 causes obesity and postpartum depression
Li, Y., Cacciottolo, T. M., Yin, N., He, Y., Liu, H., Liu, H., Yang, Y., Henning, E., Keogh, J. M., Lawler, K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.001 · Cited by 42
Targeting cancer cachexia: Molecular mechanisms and clinical study
Wang, Y., An, Z.-Y., Lin, D., & Jin, W. (2022) · MedComm · doi:10.1002/mco2.164 · Cited by 45
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
Borner, T., Reiner, B. C., Crist, R. C., Furst, C. D., Doebley, S. A., Halas, J. G., Ai, M., Samms, R. J., Jonghe, B. C. D., & Hayes, M. R. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101743 · Cited by 40
Self-citation
GDF15 links adipose tissue lipolysis with anxiety
Townsend, L. K., Wang, D., Knuth, C. M., Fayyazi, R., Mohammad, A., Becker, L. J., Tsakiridis, E. E., Desjardins, E. M., Patel, Z., Valvano, C. M., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01264-3 · Cited by 43
The human placenta and its role in reproductive outcomes revisited
Aye, I. L. M. H., Tong, S., Jones, D. S., & Smith, G. C. S. (2025) · Physiological Reviews · doi:10.1152/physrev.00039.2024 · Cited by 49
Camptothecin effectively treats obesity in mice through GDF15 induction
Lu, J. F., Zhu, M., Xie, B., Shi, X., Liu, H., Zhang, R. X., Xia, B., & Wu, J. W. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001517 · Cited by 40
Gastrointestinal inflammation plays a critical role in chemotherapy-induced nausea and vomiting
Chen, W., Zhao, Y., Dai, Y., & Nie, K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175379 · Cited by 41
Emerging roles of growth differentiation factor‑15 in brain disorders (Review)
Jiang, W., Zhang, Z., He, P., Jiang, L., Chen, J.-Z., Zhang, X.-T., Hu, M., Zhang, Y.-K., & Ouyang, X.-P. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10705 · Cited by 40
Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, “futile” fatty acid cycling, and FADH2 oxidation
Abrosimov, R., Baeken, M. W., Hauf, S., Wittig, I., Hajieva, P., Perrone, C. E., & Moosmann, B. (2024) · GeroScience · doi:10.1007/s11357-023-01059-y · Cited by 37
Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis
Guo, X., Asthana, P., Zhai, L., Cheng, K. W., Gurung, S., Huang, J., Wu, J., Zhang, Y., Mahato, A. K., Saarma, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45452-3 · Cited by 44
Cardiac Endocrinology
Zhao, J., & Pei, L. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.05.007 · Cited by 36
Associations Between Elevated Growth Differentiation Factor-15 and Sarcopenia Among Community-dwelling Older Adults
Kim, M., Walston, J. D., & Won, C. W. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab201 · Cited by 38
GDNF family receptor alpha‐like antagonist antibody alleviates chemotherapy‐induced cachexia in melanoma‐bearing mice
Lee, B. Y., Jeong, J., Jung, I., Cho, H., Jung, D., Shin, J., Park, J.-K., Park, E., Noh, S., Shin, S., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13219 · Cited by 33
Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide
Voilquin, L., Danneskiold‐Samsøe, N. B., Nguyen, Q., Wiggenhorn, A. L., Zhao, M., Wang, D. C., Toomer, D. J., Lone, J. B., Wei, Y., Patel, A. N., et al. (2025) · Nature · doi:10.1038/s41586-025-08683-y · Cited by 34
Activation of GFRAL+ neurons induces hypothermia and glucoregulatory responses associated with nausea and torpor
Engström, L., Font‐Gironès, F., Zajdel, J., Kern, L., Teixidor-Deulofeu, J., Mannerås-Holm, L., Carreras, A., Becattini, B., Björefeldt, A., Hanse, E., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113960 · Cited by 35
The metabolic basis of cancer-related fatigue
Dantzer, R., Chelette, B. M., Vichaya, E. G., West, A. P., & Grossberg, A. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106035 · Cited by 32
GDNF family receptor alpha-like (GFRAL) expression is restricted to the caudal brainstem
Hes, C., Gui, L., Bay, A., Alvarez, F., Katz, P., Paul, T., Bozadjieva-Kramer, N., Seeley, R. J., Piccirillo, C. A., & Sabatini, P. V. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102070 · Cited by 30
Semaglutide effects on energy balance are mediated by Adcyap1+ neurons in the dorsal vagal complex
Teixidor-Deulofeu, J., Sköldheden, S. B., Font‐Gironès, F., Feješ, A., Ruud, J., & Engström, L. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.018 · Cited by 37
Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases
Tian, T., Liu, M., Little, P. J., Strijdom, H., Weng, J., & Xu, S. (2025) · Research · doi:10.34133/research.0832 · Cited by 34
Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma
He, L., Li, Z., Su, D., Du, H., Zhang, K., Zhang, W., Wang, S., Xie, F., Qiu, Y., Ma, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202403858 · Cited by 31
GDF15: a potential therapeutic target for type 1 diabetes
Sarkar, S., Melchior, J., Henry, H. R., Syed, F., Mirmira, R. G., Nakayasu, E. S., & Metz, T. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2029410 · Cited by 31
Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans
Lemmelä, S., Wigmore, E. M., Benner, C., Havulinna, A. S., Ong, R. M., Kempf, T., Wollert, K. C., Blankenberg, S., Zeller, T., Peters, J. E., et al. (2022) · eLife · doi:10.7554/elife.76272 · Cited by 28
Assessment and Management of Appetite Loss in Older Adults: An ICFSR Task Force Report
Barreto, P. D. S., Cesari, M., Morley, J. E., González-Bautista, E., Rolland, Y., Azzolino, D., Vellas, B. J., Fielding, R. A., Andrieu, S., Aubertin‐Leheudre, M., et al. (2022) · The Journal of Frailty & Aging · doi:10.14283/jfa.2022.64 · Cited by 28
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation
Fung, E., Kang, L., Sapashnik, D., Benard, S., Sievers, A., Liu, Y., Yan, G. G., Zhou, J. W., Rodriguez, L., Ma, W., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87959-5 · Cited by 24
Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment
Reiner, B. C., Crist, R. C., Borner, T., Doyle, R. P., Hayes, M. R., & Jonghe, B. C. D. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101422 · Cited by 26
Self-citation
Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
Albuquerque, B., Chen, X., Hirenallur-Shanthappa, D. K., Zhao, Y. W., Stansfield, J. C., Zhang, B. B., Sheikh, A. Q., & Wu, Z. (2022) · Cells · doi:10.3390/cells11071073 · Cited by 24
The clinical potential of GDF15 as a “ready-to-feed indicator” for critically ill adults
Dyck, L. V., Gunst, J., Casaer, M. P., Peeters, B., Derese, I., Wouters, P. J., de Zegher, F., Vanhorebeek, I., & den Berghe, G. V. (2020) · Critical Care · doi:10.1186/s13054-020-03254-1 · Cited by 24
The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker
Paepe, B. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113180 · Cited by 24
A second‐generation glucagon‐like peptide‐1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models
Borner, T., Shaulson, E. D., Tinsley, I. C., Stein, L. M., Horn, C. C., Hayes, M. R., Doyle, R. P., & Jonghe, B. C. D. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14089 · Cited by 23
Self-citation
Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling
Feetham, C. H., Collabolletta, V., Worth, A. A., Shoop, R., Groom, S., Harding, C., Boutagouga Boudjadja, M., Coskun, T., Emmerson, P. J., D’Agostino, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54367-y · Cited by 22
Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior
Gil, C. I., Coull, B. M., Jonas, W., Lippert, R. N., Klaus, S., & Klaus, S. (2022) · Life Science Alliance · doi:10.26508/lsa.202201495 · Cited by 26
Cisplatin‐Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions
Huang, K., Chiang, Y., Ali, M. R., & Hsia, S. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13817 · Cited by 25
Human OPRM1 and murine Oprm1 promoter driven viral constructs for genetic access to μ-opioidergic cell types
Salimando, G. J., Tremblay, S., Kimmey, B. A., Li, J., Rogers, S. A., Wojick, J. A., McCall, N. M., Wooldridge, L. M., Rodrigues, A., Borner, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41407-2 · Cited by 19
Self-citation
Prospective Associations of Plasma Growth Differentiation Factor 15 With Physical Performance and Cognitive Functions in Older Adults
He, L., Barreto, P. D. S., Sánchez‐Sánchez, J. L., Rolland, Y., Guyonnet, S., Parini, A., Lucas, A., Vellas, B. J., MAPT/DSA Group, Vellas, B. J., et al. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac020 · Cited by 24
Cross-species comparison of pregnancy-induced GDF15
Klein, A. B., Ranea‐Robles, P., Nicolaisen, T. S., Gil, C., Johann, K., Quesada, J. P., Pistolevij, N., Hviid, K. V. R., Olsen, L. F., Offersen, S. M., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00134.2023 · Cited by 21
Central mechanisms of emesis: A role for GDF15
Borner, T., Pataro, A. M., & Jonghe, B. C. D. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14886 · Cited by 20
Self-citation
Targeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging Challenges
Zhang, J., Sun, J., Li, J., & Xia, H. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70251 · Cited by 21
Mechanisms and pharmacotherapy of cancer cachexia‐associated anorexia
Sato, R., da Fonseca, G. W. P., das Neves, W., & von Haehling, S. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70031 · Cited by 23
Metabolic Messenger: growth differentiation factor 15
Breit, S. N., & Tsai, V. W.-W. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01353-3 · Cited by 23
Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging
Min, S. H., Kang, G. M., Park, J.-W., & Kim, M. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0131 · Cited by 20
Neural pathways of nausea and roles in energy balance
Zhang, C. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102963 · Cited by 19
Tumor-immune-neural circuit disrupts energy homeostasis in cancer cachexia
Shi, X., Arreola, A. X., Zhou, Z., Yang, J., Liu, M., Cai, Y., Ren, Y., Yuan, H., Chen, Q., Chen, X., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.01.014 · Cited by 22
The development and benefits of metformin in various diseases
Dong, Y., Qi, Y., Jiang, H., Tian, M., Zhang, Y., Peng, C. S., Li, W.-C., Zhang, Y., Zhou, Y., Zang, Y., et al. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0998-6 · Cited by 21
Creation of a Peptide Antagonist of the GFRAL–RET Receptor Complex for the Treatment of GDF15-Induced Malaise
Borner, T., Tinsley, I. C., Milliken, B. T., Doebley, S. A., Najjar, N. R., Kerwood, D. J., Jonghe, B. C. D., Hayes, M. R., & Doyle, R. P. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00667 · Cited by 18
Self-citation
Food allergy: begin at the skin, end at the mast cell?
Lukacs, N. W., & Hogan, S. P. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01185-y · Cited by 21
Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons
Boccia, L., Borner, T., Ghidewon, M. Y., Kulka, P., Piffaretti, C., Doebley, S. A., Jonghe, B. C. D., Grill, H. J., Lutz, T. A., & Foll, C. L. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101444 · Cited by 18
Self-citation

Authors: Borner, T., Shaulson, E. D., Ghidewon, M. Y., Barnett, A. B., Horn, C. C., Doyle, R. P., Grill, H. J., Hayes, M. R., & De Jonghe, B. C.
Affiliations: University of Pennsylvania (US)
University of Pittsburgh (US)
SUNY Upstate Medical University (US)
ORCID: Borner, Tito
Shaulson, Evan D.
Horn, Charles C.
Doyle, Robert P.
Grill, Harvey J.
Hayes, Matthew R.
Venue: Cell Metabolism
Publisher: Elsevier BV
Published: 2020-02
Volume: 31
Issue: 2
Pages: 351-362.e5
ISSN: 1550-4131 (ISSN-L)
DOI: 10.1016/j.cmet.2019.12.004
PMC: PMC7161938
OpenAlex: W3000046815
Cited by: 255
References: 64
Citations by year: 2026: 37 · 2025: 42 · 2024: 47 · 2023: 28 · 2022: 41 · 2021: 35 · 2020: 25
FWCI: 16.56
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 369 d)
Locations: Cell Metabolism (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Schweizerischer Nationalfonds zur FÃ¶rderung der Wissenschaftlichen Forschung (P2ZHP3_178114, P400PB_186728)
National Institutes of Health (DK-112812, DK-115762, CA-201962, DK-021397)
Topics: Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
Health Sciences › Medicine › Surgery › Nausea and vomiting management
Keywords: GDF15, growth differentiation factor 15, anorexia, nausea, vomiting, pica, obesity treatment, feeding behavior, Suncus murinus, mice, rats
MeSH terms: Animals, Anorexia, Body Weight, Female, Humans, Hypoglycemic Agents, Male, Mice, Inbred C57BL, Nausea, Recombinant Proteins, Shrews, Vomiting, Rats, Sprague-Dawley, Mice, Rats, Growth Differentiation Factor 15

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

GDF15 Induces Anorexia through Nausea and Emesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks